General Information

The Journal of Heart Valve Disease (ISSN 0966-8519) is the official journal of The Society for Heart Valve Disease. It is indexed/abstracted by Index Medicus, Medline, Medlar, PubMed, Science Citation Index, Scisearch, Research Alert, Biomedical Products, Current Contents/Clinical Medicine. It is issued bi-monthly in one indexed volume by ICR Publishers Ltd., Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom. This paper meets the requirements of ANSI standard Z39.48-1992 (Permanence of Paper).

Subscription rates:

Individual Subscription: $300 hard copy and online, $250 hard copy only, $200 online only.
Individual subscription will be delivered only to a private address. Online access through user name and password to one e-mail address only.

Institutional Subscription: Hard copy and online - see list below per site +$50. Hard copy only - $400. Online only see list below.

Institutional Online: Institutional subscribers receive a one-year licence for online access through IP addresses. FTE in this context means "Authorized Users", who are authenticated, authorized current full and part time students, employees (including faculty, staff, affiliated researchers and independent contractors), and other individuals who have permission to use the public computers on an Institutional Subscriber's geographically constrained site. A "site" is an organizational unit, and may be academic or non-academic. For organizations located in more than one city, each city office is considered a different site. For organizations within the same city that are administered independently, each office is considered a different site. Institutional subscribers with more than one site must subscribe for each site separately.

Number of FTE per site

2-100
101-500
501-1,000
1,001-5,000
5,001-10,000
10,001-25,000
>25,000

IP range per site: Unlimited

Annual Subscription fee

$500.00
$650.00
$750.00
$900.00
$1,000.00
$1,250.00
$1,500.00

The online access includes
* Access to PDF full-text articles from current content and all online back files to January 1st 2003;
* Access to online early articles where available, i.e. peer-reviewed articles published online before the print issue is completed.
* Access to abstracts from 1999 is free.

Print - per issue 2012: $ 80.00 per copy

Back issues - are available on request, for prices please contact ICR Publishers, icrfinance@aol.com

Mail and supplements - included in the subscription.

Delivery: by air-lift/surface - mail.

Method of payment:

By bank transfer
National Westminster Bank plc
Marylebone and Harley Street Branch
Sort code: 50 30 25
Account name: ICR Publishers, Ltd.
Account number: 140/00/03232727
NXBFLGKD-USD00
SWIFT Code: NWBK GB 2L
IBAN No.: GB70 NWBK 6073 0103 2327 27
By check
All checks must be drawn on a USA bank, made payable to ICR Publishers, and sent to
ICR Publishers,
Crispin House,
12A South Approach, Moor Park,
Northwood HA6 2ET, United Kingdom.

Online by credit card - Master card, Visa, Delta and American Express are accepted. Credit card payment can be made online at - www.icr-heart.com

Cancellation policy: Subscription may not be canceled and subscription fee is not refundable.

Inquires about single copies, back issues, claims for missing copies, report of changes of address should be directed to:
ICR Publishers Ltd., Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom. In Japan: Nankodo Co. Ltd. 92-6 Hongo
3-Chome Bunkyo-ku, Tokyo 113.

Claims for missing issues will be accepted for up to three months. However, no claim will be honored if ICR Publishers were not notified of change of address and the delivery was made to the original address.

Address
Manuscripts and all editorial correspondence should be sent electronically to: submit-jhvd.icr-heart.com

Reprint: The minimum number of reprints that can be ordered is 500 copies per article. Orders for smaller quantities will be accepted only exceptionally, and they will not be subsidized by the publisher. However, all corresponding authors will receive, by e-mail, the .PDF file of the article, which they can print in as many copies as necessary to provide hard copies for themselves, for the co-authors and others interested in receiving a reprint. This service will be automatic and free of charge. These reprints, however, must not be used for any commercial purposes.

Orders for 500 copies or larger quantities should be sent to ICR Publishers, Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom.

Advertising: Inquires should be made to:
ICR Publishers, Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom.
Telephone: 44 1923 836 871, fax: 44 1923 836 872
e-mail: icrfinance@aol.com
All advertising material published in The Journal of Heart Valve Disease is expected to conform to ethical/medical standards. However, the inclusion in this publication does not constitute a guarantee or endorsement by the Editors or the Publisher of the quality or value of such product or of the claim made for it by its manufacturer.

Copyright©: The Journal of Heart Valve Disease, all publications in it whether in toto or in part are protected by copyright held by ICR Publishers Ltd. The Publisher reserves all rights. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the Publisher. Notwithstanding the aforementioned restrictions, the Publisher grants consent for the copying of articles for personal or internal use. This consent does not extend to any other kinds of copying, such as for resale, advertising, commercial promotion, general distribution or inclusion into new collective work.

Disclaimer: The Journal of Heart Valve Disease endeavours to publish only material representing the highest scientific standards. However, by publishing any material in any format in the Journal, no responsibility is assumed by the Editors and the Publisher for any damage or injury to institution, person or property in any way, including but not limited to product liability, negligence or otherwise, particularly if resulting from the use of any product, method, whether preventive, diagnostic or therapeutic, ideas, explicit or implicit suggestions or instructions. Any device/ equipment/pharmaceutical should be used and any procedure should be implemented solely on the responsibility of the acting physician. Results, opinions, recommendations, or any other statements published in The Journal of Heart Valve Disease represent the authors' view and, unless specifically stated otherwise, not the official policy of the Journal or The Society for Heart Valve Disease.